Loading clinical trials...
Loading clinical trials...
The aim of this study is to describe the natural history of patients with alpha-1 antitrypsin associated emphysema and to figure out associated prognostic factors.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
NCT06389877 · Alpha 1-Antitrypsin Deficiency
NCT06996756 · Alpha 1-Antitrypsin Deficiency
NCT06891755 · COPD, Emphysema
NCT03500731 · Idiopathic Pulmonary Fibrosis, Emphysema or COPD
NCT07059637 · COPD, Emphysema, and more
Departement d'épidémiologie, Hôpital Bichat
Paris
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions